Syngene International (India) Today
| SYNGENE Stock | 720.20 5.95 0.83% |
PerformanceVery Weak
| Odds Of DistressLow
|
Syngene International is trading at 720.20 as of the 27th of March 2025, a 0.83 percent increase since the beginning of the trading day. The stock's lowest day price was 710.15. Syngene International has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of December 2024 and ending today, the 27th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Syngene International is entity of India. It is traded as Stock on NSE exchange. The company has 401.36 M outstanding shares. More on Syngene International Limited
Moving together with Syngene Stock
| 0.76 | SBIN | State Bank | PairCorr |
| 0.62 | ONGC | Oil Natural Gas | PairCorr |
| 0.79 | TCS | Tata Consultancy Services | PairCorr |
Moving against Syngene Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Syngene Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Syngene International's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Syngene International or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO MD | Jonathan Hunt | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Syngene International's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Syngene International's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsSyngene International can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Syngene International's financial leverage. It provides some insight into what part of Syngene International's total assets is financed by creditors.
| |||||
Syngene International Limited (SYNGENE) is traded on National Stock Exchange of India in India and employs 6,510 people. Syngene International is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 289.06 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Syngene International's market, we take the total number of its shares issued and multiply it by Syngene International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Syngene International operates under Biotechnology sector and is part of Health Care industry. The entity has 401.36 M outstanding shares.
Syngene International Limited has accumulated about 0 in cash with 10.42 B of positive cash flow from operations.
Check Syngene International Probability Of Bankruptcy
Ownership AllocationSyngene International shows a total of 401.36 Million outstanding shares. Syngene International maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Syngene Ownership Details
Syngene International Risk Profiles
Although Syngene International's alpha and beta are two of the key measurements used to evaluate Syngene International's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.24 | |||
| Standard Deviation | 1.69 | |||
| Variance | 2.87 | |||
| Risk Adjusted Performance | (0.11) |
Syngene Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Syngene International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Syngene International Corporate Management
Elected by the shareholders, the Syngene International's board of directors comprises two types of representatives: Syngene International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Syngene. The board's role is to monitor Syngene International's management team and ensure that shareholders' interests are well served. Syngene International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Syngene International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mahesh Bhalgat | Chief Officer | Profile | |
| Sibaji Biswas | Chief Officer | Profile | |
| Ajit Manocha | Head IT | Profile | |
| Chetan Tamhankar | Head Studies | Profile | |
| Jayashree Aiyar | Chief Officer | Profile | |
| Sandeep Nair | Head Communications | Profile |
Other Information on Investing in Syngene Stock
Syngene International financial ratios help investors to determine whether Syngene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Syngene with respect to the benefits of owning Syngene International security.